Search - tctmd.com

Displaying 1 - 20 of 439

Sort: Relevancy | Date

Novel Strategies Can Enable Fair Access to Heart Transplantation

News Opinion Off Script

Novel Strategies Can Enable Fair Access to Heart Transplantation

Maryjane Farr, MD

March 13, 2026

AI for Heart Failure Care Is Evolving Rapidly, THT 2026 Makes Clear

News Conference News THT 2026

AI for Heart Failure Care Is Evolving Rapidly, THT 2026 Makes Clear

March 10, 2026

Should Moderate FMR Should Be Treated With M-TEER? Experts Duke It Out

News Conference News THT 2026

Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out

March 06, 2026

Experience Matters as Ross Procedure Gains Popularity in North America

News Daily News

Experience Matters as Ross Procedure Gains Popularity in North America

Michael O'Riordan

March 06, 2026

Advanced HF in Finland: Costs, Survival Diverge for Elective vs Urgent LVAD

News Daily News

Advanced HF in Finland: Costs, Survival Diverge for Elective vs Urgent LVAD

March 06, 2026

Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought

News Conference News THT 2026

Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought

March 04, 2026

Presentation THT 2026

LVAD Combined with hiPSC-Cardiomyocyte Transplantation for Advanced Heart Failure: Preliminary Safety and Functional Recovery Results from a Randomized Trial

Presenter: yongfeng Shao

March 03, 2026

Presentation THT 2026

Variation in Primary Graft Dysfunction Prevalence and Management Across Heart Transplant Centers

Presenter: Malachy Belkhelladi

March 03, 2026

Presentation THT 2026

Heart Transplantation for Primary Cardiac Tumors: A Systematic Review of Survival and Recurrence Outcomes

Presenter: Warren Fernandes

March 03, 2026

Presentation THT Abstracts 2026

Impact of the 2018 Heart Allocation Policy Change on Heart–Lung Transplant Outcomes: A Survival Analysis Using SRTR Data

Presenter: Daniella Galtes

March 02, 2026

Presentation THT 2026

Longitudinal ImmuKnow Monitoring One Year After Heart Transplant: Associations with Rejection, Infection, and Cardiac Allograft Vasculopathy 

Presenter: David Golombeck

March 02, 2026

Presentation THT 2026

Comparing Predictors of Readmission in LVAD Patients Bridged to Transplant: Psoas Muscle Index versus Pre-Albumin

Presenter: Matthew Ramm

March 02, 2026

Presentation THT Abstracts 2026

Comparative risk of statin therapy on adverse cardiovascular outcomes in heart transplant recipients

Presenter: Stephen J. Foley

March 02, 2026

Presentation THT 2026

Heart Transplantation in Adults Over 70 Years: National Trends and Center-Level Variability

Presenter: Dena E. Hayes

March 02, 2026

Presentation THT 2026

Characterizing Hemodynamic Phenotypes In Patients Not Meeting Diagnostic Criteria for Primary Graft Dysfunction

Presenter: Caroline Magro

March 02, 2026

Presentation THT 2026

Characterizing the Untapped Pool of HIV+ Donors for Heart Transplantation

Presenter: Neha Parvathala

March 02, 2026

Presentation THT 2026

Not Quite PGD: Classification of Abnormal Hemodynamic Phenotypes after Heart Transplant

Presenter: Jordan Liebman

March 02, 2026

Presentation THT 2026

Comparing the Strategy of LVAD versus Heart Transplantation Listing by Age in National US Data: Informing Patient Centered Decision Making

Presenter: Thomas Cascino

March 02, 2026

Presentation THT Abstracts 2026

Persistently Elevated Donor-Derived Cell-Free DNA After Heart Transplant: A Clinical Dilemma

Presenter: David Golombeck

March 02, 2026

AF Common, Worsens Prognosis After Stem Cell Transplant for Multiple Myeloma

News Daily News

AF Common, Worsens Prognosis After Stem Cell Transplant for Multiple Myeloma

February 24, 2026

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.